Dysmenorrhea PrimaryCentral SensitisationMyofascial Trigger Point PainMenstrual DiscomfortMyofascial Release
Investigational drug(s) / intervention(s)
Myofascial ReleaseSham-Myofascial Release
Myofascial Release: The myofascial release technique is a widely used manual therapy method characterized by low-load, prolonged mechanical forces applied to manipulate the myofascial complex, aiming to restore optimal length, alleviate pain, and improve function.
Sham-Myofascial Release: The hands of the researcher applying the technique will be placed in the same areas as the myofascial release technique, with only the palms in light contact for the same duration. However, no intervention will be made to create any pressure or open the tissue barrier.
Study summary
It has been found that women with dysmenorrhea have active trigger points, particularly in the rectus abdominis, oblique abdominal muscles, quadratus lumborum, and paraspinal muscles. The myofascial release technique is a widely used manual therapy method characterized by the application of low-load, long-duration mechanical forces to manipulate the myofascial complex. This technique aims to restore optimal length, alleviate pain, and improve function. This study aims to examine the effect of the myofascial release technique on central sensitization, myofascial trigger points, and menstrual symptoms in women with primary dysmenorrhea.
Eligibility
Sex
FEMALE
Min age
18 Years
Max age
35 Years
Healthy volunteers
No
Inclusion Criteria:
* Diagnosed with Primary Dysmenorrhea according to the Primary Dysmenorrhea Consensus Guide,
* Having regular menstruation in the last 6 months (28±7 days)
* Those who had menstrual pain between 40 mm and 100 mm according to the Visual Analogue Scale (VAS) in the last 6 months
Exclusion Criteria:
* Diagnosed with Secondary Dysmenorrhea,
* Having given birth,
* Those with serious gastrointestinal, urogynecological, or autoimmune diseases or other chronic pain syndromes,
* Undergoing urogynecological surgery,
* Those who are pregnant or suspected of pregnancy,
* Those who use analgesics or non-pharmacological agents other than NSAIDs for menstrual pain,
* Those using intrauterine or oral contraceptives,
* Those taking extra supplements such as magnesium, which may affect treatment
Primary outcome measure(s)
Pain Pressure Threshold — Baseline (First menstruation cycle) Trigger points in specific muscles (rectus abdominis, paraspinal muscles, quadratus lumborum, gluteus maximus) will be determined. Then, it will be applied to the trigger points with the Baseline brand algometer in accordance with standard procedures and the pressure will be increased by 30 kPa/s.
Pain Pressure Threshold — through study completion, an average of 3 months Trigger points in specific muscles (rectus abdominis, paraspinal muscles, quadratus lumborum, gluteus maximus) will be determined. Then, it will be applied to the trigger points with the Baseline brand algometer in accordance with standard procedures and the pressure will be increased by 30 kPa/s.
Central Sensitization — Baseline (First menstruation cycle) Pain threshold will be measured with an algometer at a certain point of the tibialis muscle.
Central Sensitization — through study completion, an average of 3 months Pain threshold will be measured with an algometer at a certain point of the tibialis muscle.
Menstrual pain intensity — Baseline (First menstruation cycle) Menstrual pain intensity will be determined by a 10 cm Visual Analog Scale ranging from zero (no pain at all) to 10 (worst pain I have ever felt). Higher scores mean worse conditions. Participants will be asked to mark the severity of pain they felt in the first 3 days of their last menstrual bleeding on 3 separate lines.
Menstrual pain intensity — through study completion, an average of 3 months Menstrual pain intensity will be determined by a 10 cm Visual Analog Scale ranging from zero (no pain at all) to 10 (worst pain I have ever felt). Higher scores mean worse conditions. Participants will be asked to mark the severity of pain they felt in the first 3 days of their last menstrual bleeding on 3 separate lines.
Trial sites (1)
Facility
City
Region
Status
Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Gazi University
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.